Navigation Links
July 2008 Mayo Clinic Health Letter Highlights Bone Health, Causes of Swelling and Slimmed-Down Desserts
Date:7/14/2008

ROCHESTER, Minn., July 14 /PRNewswire-USNewswire/ -- Here are highlights from the July issue of Mayo Clinic Health Letter. You may cite this publication as often as you wish. Reprinting is allowed for a fee. Mayo Clinic Health Letter attribution is required. Include the following subscription information as your editorial policies permit: Visit http://www.HealthLetter.MayoClinic.com or call toll-free for subscription information, 1-800-333-9037, extension 9PR1.

Test Your Knowledge of Bone Health

ROCHESTER, Minn. -- Knowing key facts about bone health can help reduce the risk of osteoporosis, a disease that causes bones to become weak, brittle and prone to fracture. Bone loss that leads to osteoporosis often can be slowed by:

-- Getting adequate calcium and vitamin D

-- Doing weight-bearing exercise and strength training

-- Limiting alcohol consumption

-- Stopping smoking

The July issue of Mayo Clinic Health Letter includes this short true-or-false quiz on bone health:

Being overweight reduces the risk of osteoporosis.

True: Weight has a powerful impact on bone mass. Because weight increases the load on your skeleton, bones compensate by growing stronger to support the weight. But the benefit isn't an excuse to gain weight or not to lose weight, for those who are overweight. Instead, thinner or smaller adults -- who have weighed less than 127 pounds for much of their lives -- tend to have lower bone density and may want to emphasize weight-bearing exercise such as walking or jogging to increase their skeletal load.

Taking testosterone isn't effective at warding off osteoporosis in older men.

False: Men with very low testosterone levels are at increased risk of osteoporosis and can perhaps improve their bone density with testosterone replacement. This therapy also may help men with low testosterone strengthen muscles an
'/>"/>

SOURCE Mayo Clinic
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Radiologists encouraged to look beyond cancer for clinically unseen diseases
3. Clinical depression linked to abnormal emotional brain circuits
4. Preclinical study suggests organ-transplant drug may aid in lupus fight
5. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
6. AASM encourages those student-athletes at risk for developing osa to visit a sleep clinic
7. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
8. MinuteClinic Becomes Participating Provider with Assurant Health
9. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
10. Acupuncturists Relocation Tightens Relationship With Fertility Clinic
11. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...Pa., Nov. 21 During a ... Edward G. Rendell today remembered Lieutenant Gov... an important partner in public service, and a tir... , "As the first woman elected lieutenant gov...rvant," said Governor Rendell. "Her family and her...
(Date:11/21/2008)...ers remain cautious about future antibiotic resist...ov. 21 (HealthDay News) -- People with moderate to...D) may be able to reduce the frequency of exacerba...biotic, a new report says. , The study, publis...an Journal of Respiratory and Critical Care Medici...
(Date:11/21/2008)...W.Va., Nov. 21 New rese...ether a smokeless, spitless tobacco product aimed ...s have found that RJ Reynolds, Camel Snus - touted... - contains surprisingly high levels of nicotine. ... most other snuff products," said Bruce Adkins of ...
(Date:11/21/2008)...v. 21 The general membership of th...t three new individuals at their Annual,Awards Di...tel in New York. A,Lifetime Achievement Award wil...the Medical Advertising Hall of Fame are: , Ron...h an account position,at Sudler & Hennessey. ...
Breaking Medicine News(10 mins):Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 2Health News:Pennsylvania Governor Rendell Remembers, Celebrates the Life of Lt. Governor Catherine Baker Knoll During Capitol Tribute 3Health News:Long-Term Erythromycin Cut COPD Complications 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3
... have discovered a naturally occurring hormone tha...%. Mice lacking the gene for klotho began showing ...e and die after // about two months when compared ...is has indeed opened up new avenues into improving...
... report published in the latest edition of The Lan...n treating adults with malaria than the common dru...r the treatment // of severe malaria throughout Af... But even with prompt administration of the drug i...
...ug 26 . Japanese encephalitis deaths continue to r...ed 220 in less than a month. // Dr.T.N.Dhole from...i Post Graduate Institute of Medical Sciences bla... spread of the killer brain fever, which had been ...
...n country of Uganda reports that all the efforts t...ing. The report on this topic was reported in this...nosoma brucei rhodesiense sleeping // sickness in ...lt of the movement of the livestock reservoir of t...
Other Medicine News:Health News:Encephalitis Deaths Cross 220 in Uttar Pradesh 2
(Date:11/20/2008)...Newswire/ -- Radius Health ("Radius") announced to...o its second institutional financing round, increa...d the total amount raised since the company,s ince...l investors participated in the financing, led by ...pital, The Wellcome Trust, HealthCare Ventures, Ox...
(Date:11/19/2008)...9 Amgen,(Nasdaq: AMGN...subsidiary of,Takeda Pharmaceutical Company Limit...n the Phase 3 MONET1 trial evaluating motesanib (A...latin for the first-line treatment of,advanced no...ily suspended,following a planned safety data rev...
(Date:11/19/2008)...from Roche- , , MONTVALE, N.J., Nov. 19 /PR.... (Nasdaq: MEMY ) today announced that it has ac...f R3487/MEM 3454, its lead alpha-7 nicotinic recep...th schizophrenia (CIAS). The Company has randomiz... $5.0 million payment from its partner Roche. Mem...
(Date:11/18/2008)...008 Faces of Influenza survey underscores that mot...nza; Mother and Gold Medalist Kristi Yamaguchi joi...ewswire/ -- While 78 percent of mothers in the Uni...ally life-threatening disease that can strike anyo... get vaccinated this season, according to a new su...
Breaking Medicine Technology:Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 2Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 3Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 4Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 5Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Don't Get Their Families Vaccinated 6Dense tissue promotes aggressive cancers 4581 1Dense tissue promotes aggressive cancers 4581 2Vermillion Announces Publication of Data Supporting Its Peripheral Artery Disease Diagnostic Test Program 25689 1Vermillion Announces Publication of Data Supporting Its Peripheral Artery Disease Diagnostic Test Program 25689 2Vermillion Announces Publication of Data Supporting Its Peripheral Artery Disease Diagnostic Test Program 25689 3RMA of Michigan Hosts 1st Metro Detroit Area Hope Uncorked 3A Exclusive Wine Tasting Event To Benefit Fertile Hope 25687 1RMA of Michigan Hosts 1st Metro Detroit Area Hope Uncorked 3A Exclusive Wine Tasting Event To Benefit Fertile Hope 25687 2The challenge of paying for quality nursing care 25685 1The challenge of paying for quality nursing care 25685 2
...nix Medical,Corporation (OTC BB: CONX) and the Com...l data demonstrating a significant correlation,bet...x(TM),bio-markers and cardiovascular disease. The ...ternational Society on Thrombosis and,Hemostasis (...week shows the association of antibodies to,the At...
... Portola,Pharmaceuticals, Inc. announced positive ...oral Factor Xa inhibitor, today at the XXI,Congres...aemostasis,(ISTH) in Geneva, Switzerland. The EXPE..., and well tolerated for the,prevention of venous ... total knee replacement (TKR) surgery. Portola exp...
Other Medicine Technology:Corgenix Reports New Clinical Data Correlating AtherOx Technology,With Vascular Disease 2Corgenix Reports New Clinical Data Correlating AtherOx Technology,With Vascular Disease 3Corgenix Reports New Clinical Data Correlating AtherOx Technology,With Vascular Disease 4Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 2Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 3Portola Pharmaceuticals Announces Positive Data from a Phase II,Study of its Factor Xa Inhibitor at the XXI Congress of the,International Society on Thrombosis and Haemostasis 4
Keeler Professional Combi Retinoscope with new slimline handle and lithium or dry cell option.
300XL System, English (U.K. cord), 100-240 VAC.
Micro-mini fiber optic light.
Xenon technology achieves a higher efficiency than halogen light sources. Consequently they provide more light.
Medicine Products: